As of 9:30 AM on the 11th, Seegene is trading at 249,500 KRW, down 0.64% from the previous day. This represents a 12.69% increase compared to August 14. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

Over the past five days, individual investors have net sold 154,999 shares, while foreigners and institutions have net sold 74,658 shares and net bought 236,784 shares, respectively.


On September 8, Seegene was a market highlight with the news of the "strong launch of new COVID-19 and flu differential diagnostic products worldwide."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing